Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
BDX

Price
177.38
Stock movement down
-1.05 (-0.57%)
Company name
Becton Dickinson and Company
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Instruments & Supplies
Market cap
52.47B
Ent value
81.00B
Price/Sales
2.39
Price/Book
2.08
Div yield
2.28%
Div growth
5.97%
Growth years
49
FCF payout
45.33%
Trailing P/E
29.86
Forward P/E
13.48
PEG
3.28
EPS growth
13.56%
1 year return (CAGR)
2.87%
3 year return (CAGR)
-1.26%
5 year return (CAGR)
-1.28%
10 year return (CAGR)
5.91%
Last updated: 2026-02-23

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share4.20
Dividend yield2.28%
Payout frequencyQuarterly
Maximum yield2.58%
Average yield1.62%
Minimum yield1.23%
Discount to avg yield29.10%
Upside potential41.04%
Yield as % of max yield88.45%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield2.28%
Current yield distribution6.35%
Yield at 100% (Min)1.23%
Yield at 90%1.33%
Yield at 80%1.37%
Yield at 50% (Median)1.51%
Yield at 20%1.83%
Yield at 10%2.18%
Yield at 0% (Max)2.58%

Dividend per share

Loading...
Dividend per share data
Years of growth49 years
CCC statusDividend Champion
Dividend per share4.20
Payout frequencyQuarterly
Ex-div date10 Mar 2026
EPS (TTM)6.16
EPS (1y forward)13.68
EPS growth (5y)13.56%
EPS growth (5y forward)9.10%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
BDXS&P500
DGR MR27.20%-13.74%
DGR TTM12.20%6.60%
DGR 3 years6.03%7.31%
DGR 5 years5.97%4.69%
DGR 10 years5.69%6.30%
DGR 15 years7.14%8.16%
Time since last change announced29 days
EPS growth (5y)13.56%
EPS growth (5y forward)9.10%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM67.90%45.33%
Average--
Forward30.71%-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E29.86
Price to OCF15.46
Price to FCF19.94
Price to EBITDA14.52
EV to EBITDA22.42

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.39
Price to Book2.08
EV to Sales3.69

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count284.63M
EPS (TTM)6.16
FCF per share (TTM)9.23

Income statement

Loading...
Income statement data
Revenue (TTM)21.92B
Gross profit (TTM)10.03B
Operating income (TTM)2.72B
Net income (TTM)1.76B
EPS (TTM)6.16
EPS (1y forward)13.68

Margins

Loading...
Margins data
Gross margin (TTM)45.76%
Operating margin (TTM)12.40%
Profit margin (TTM)8.01%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash1.02B
Net receivables2.51B
Total current assets9.19B
Goodwill26.62B
Intangible assets9.03B
Property, plant and equipment15.24B
Total assets54.84B
Accounts payable6.14B
Short/Current long term debt19.54B
Total current liabilities8.76B
Total liabilities29.56B
Shareholder's equity25.28B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)3.39B
Capital expenditures (TTM)763.00M
Free cash flow (TTM)2.63B
Dividends paid (TTM)1.19B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity6.95%
Return on Assets3.20%
Return on Invested Capital3.92%
Cash Return on Invested Capital5.87%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open184.75
Daily high186.30
Daily low182.13
Daily Volume2.70M
All-time high222.95
1y analyst estimate195.38
Beta0.28
EPS (TTM)6.16
Dividend per share4.20
Ex-div date10 Mar 2026
Next earnings date29 Apr 2026

Downside potential

Loading...
Downside potential data
BDXS&P500
Current price drop from All-time high-20.44%-1.82%
Highest price drop-52.27%-56.47%
Date of highest drop26 Sep 20009 Mar 2009
Avg drop from high-12.24%-10.84%
Avg time to new high19 days12 days
Max time to new high1331 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
BDX (Becton Dickinson and Company) company logo
Marketcap
52.47B
Marketcap category
Large-cap
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care
Employees
70000
Investor relations
SEC filings
CEO
Thomas Polen
Country
USA
City
Franklin Lakes
Stock type
Common stock
CCC status
Dividend Champion
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...